Skip to main content
Toggle main menu visibility
Menu
Join
Sign In
Communities
Membership
Events
Publications
Learning & Careers
AIChE Home
About
Contact AIChE
Leadership
Events
Communities
Membership
Learning & Careers
Publications
Careers at AIChE
Equity, Diversity, Inclusion
Giving
Students
Young Professionals
Operating councils
Local Sections
Committees
Awards
Communities
Membership
Events
Publications
Learning & Careers
Toggle site search visibility
Sign In
Join
Breadcrumb
Home
Publications
Proceedings
2010 Annual Meeting
Comprehensive Quality by Design in Pharmaceutical Development and Manufacture
2010 Annual Meeting
Group: Comprehensive Quality by Design in Pharmaceutical Development and Manufacture
Chairs
Shekhar K. Viswanath
, Eli Lilly & Co.
Christine Seymour
, Pfizer
Areas
Topical i : Comprehensive Quality by Design in Pharmaceutical Development and Manufacture
Sessions
November 08, 2010
08:30 AM
to
11:00 AM
Scale-up of Pharmaceutical Manufacturing Processes: Toward a QbD Approach
12:30 PM
to
03:00 PM
Model Based Integrated Design of Pharmaceutical Drug Product and Process
03:15 PM
to
05:45 PM
Quality by Design in Generic Drug Development
November 09, 2010
08:30 AM
to
11:00 AM
Challenges Facing CMC Organizations in the Changing Business and Regulatory Environment
12:30 PM
to
03:00 PM
Quality-by-Design (QbD) Round Table Discussion Session: An Integrated and Science-Based Approach for Quality by Design (QbD) Implementation in Pharmaceutical Industry
03:15 PM
to
05:45 PM
QbD Topical Plenary Session
November 10, 2010
08:30 AM
to
11:00 AM
Quality-by-Design (QbD): Techniques for Quality Risk Analysis and Management Over the Product Life Cycle
12:30 PM
to
03:00 PM
Applications of Multivariate Data Analysis in Pharmaceutical Process Development
03:15 PM
to
05:45 PM
Applications of PAT in a Manufacturing Setting
November 11, 2010
08:30 AM
to
11:00 AM
TI Application of Quality by Design in Drug Product Process Development
12:30 PM
to
03:00 PM
TI Application of Quality by Design In API Process Development
03:15 PM
to
05:45 PM
Model Based QbD in Drug Substance or Drug Product